A drug company said Friday that a medicine it sells to tamp down inflammation has helped prevent the need for breathing machines in hospitalized COVID-19 patients in the first large study that primarily enrolled Hispanics and Blacks.
While countries across the world are battling with the coronavirus pandemic, some African countries, are also battling the outbreaks of deadlier hemorrhagic fever viruses: Lassa virus and Ebola virus.
